Milan, Italy

Giovanni Mistrello

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Rome, IT (2006)
  • Milan, IT (1984 - 2020)

Company Filing History:


Years Active: 1984-2020

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Giovanni Mistrello: Innovator in Allergy Research

Introduction

Giovanni Mistrello is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of allergy research, holding a total of 10 patents. His work focuses on developing hypoallergenic variants and methods to reduce allergenicity while preserving immunogenicity.

Latest Patents

Among his latest patents is a method for creating allergoids derived from allergens. This innovative approach involves modifying allergenic materials to reduce their allergenicity while maintaining their immunogenic properties. The method utilizes functionalization of primary amine groups in lysine and arginine residues, resulting in a product that is both effective and safer for individuals with allergies. Another notable patent involves hypoallergenic variants of Mal d 1, the major allergen from Malus domestica, which has potential applications in treating allergic diseases.

Career Highlights

Giovanni Mistrello has worked with reputable organizations such as Lofarma S.p.a. and the National Research Council of Italy. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative solutions in allergy treatment.

Collaborations

Throughout his career, Mistrello has collaborated with esteemed colleagues, including Daniela Roncarolo and Paolo Falagiani. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Giovanni Mistrello's contributions to allergy research through his patents and collaborations highlight his role as an influential inventor in the field. His innovative approaches continue to pave the way for advancements in allergy treatment and management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…